| Understanding the role of the gut microbiome and microbial metabolites in non-alcoholic fatty liver disease: current evidence and perspectives N Vallianou, GS Christodoulatos, I Karampela, D Tsilingiris, F Magkos, ... Biomolecules 12 (1), 56, 2021 | 154 | 2021 |
| Remission of type 2 diabetes mellitus after bariatric surgery: fact or fiction? D Tsilingiris, C Koliaki, A Kokkinos International journal of environmental research and public health 16 (17), 3171, 2019 | 65 | 2019 |
| Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges E Amanatidou, A Gkiouliava, E Pella, M Serafidi, D Tsilingiris, ... Metabolism open 14, 100180, 2022 | 56 | 2022 |
| Vaccine induced thrombotic thrombocytopenia: the shady chapter of a success story D Tsilingiris, NG Vallianou, Ι Karampela, Μ Dalamaga Metabolism open 11, 100101, 2021 | 55 | 2021 |
| Potential implications of lipid nanoparticles in the pathogenesis of myocarditis associated with the use of mRNA vaccines against SARS-CoV-2 D Tsilingiris, NG Vallianou, I Karampela, J Liu, M Dalamaga Metabolism open 13, 100159, 2022 | 47 | 2022 |
| The association of diabetic microvascular and macrovascular disease with cutaneous circulation in patients with type 2 diabetes mellitus I Eleftheriadou, A Tentolouris, P Grigoropoulou, D Tsilingiris, I Anastasiou, ... Journal of Diabetes and its Complications 33 (2), 165-170, 2019 | 46 | 2019 |
| Follistatins in glucose regulation in healthy and obese individuals N Perakakis, A Kokkinos, N Peradze, N Tentolouris, W Ghaly, D Tsilingiris, ... Diabetes, Obesity and Metabolism 21 (3), 683-690, 2019 | 44 | 2019 |
| Anti-viral treatment for SARS-CoV-2 infection: A race against time amidst the ongoing pandemic NG Vallianou, D Tsilingiris, GS Christodoulatos, Ι Karampela, ... Metabolism open 10, 100096, 2021 | 38 | 2021 |
| Impact of waist circumference on cardiac phenotype in hypertensives according to gender K Tsioufis, D Tsiachris, M Selima, K Dimitriadis, C Thomopoulos, ... Obesity (Silver spring) 17 (1), 177-82, 2009 | 36 | 2009 |
| Of mice and men: Considerations on adipose tissue physiology in animal models of obesity and human studies IG Lempesis, D Tsilingiris, J Liu, M Dalamaga Metabolism open 15, 100208, 2022 | 31 | 2022 |
| The role of next-generation probiotics in obesity and obesity-associated disorders: Current knowledge and future perspectives NG Vallianou, D Kounatidis, D Tsilingiris, F Panagopoulos, ... International Journal of Molecular Sciences 24 (7), 6755, 2023 | 29 | 2023 |
| Plasma irisin levels in subjects with type 1 diabetes: comparison with healthy controls A Tentolouris, I Eleftheriadou, D Tsilingiris, IA Anastasiou, OA Kosta, ... Hormone and metabolic research 50 (11), 803-810, 2018 | 27 | 2018 |
| Endothelium as a therapeutic target in diabetes mellitus: from basic mechanisms to clinical practice A Tentolouris, I Eleftheriadou, E Tzeravini, D Tsilingiris, SA Paschou, ... Current medicinal chemistry 27 (7), 1089-1131, 2020 | 26 | 2020 |
| Will medications that mimic gut hormones or target their receptors eventually replace bariatric surgery? A Kokkinos, D Tsilingiris, CW le Roux, F Rubino, CS Mantzoros Metabolism 100, 153960, 2019 | 25 | 2019 |
| In vitro data of current therapies for SARS-CoV-2 IA Anastasiou, I Eleftheriadou, A Tentolouris, D Tsilingiris, N Tentolouris Current Medicinal Chemistry 27 (27), 4542-4548, 2020 | 24 | 2020 |
| Circulating chemerin and its kinetics may be a useful diagnostic and prognostic biomarker in critically ill patients with sepsis: a prospective study I Karampela, GS Christodoulatos, N Vallianou, D Tsilingiris, ... Biomolecules 12 (2), 301, 2022 | 22 | 2022 |
| The role of mitochondrial adaptation and metabolic flexibility in the pathophysiology of obesity and insulin resistance: an updated overview D Tsilingiris, E Tzeravini, C Koliaki, M Dalamaga, A Kokkinos Current Obesity Reports 10, 191-213, 2021 | 22 | 2021 |
| Telomere length, epidemiology and pathogenesis of severe COVID‐19 D Tsilingiris, A Tentolouris, I Eleftheriadou, N Tentolouris European Journal of Clinical Investigation 50 (10), 2020 | 22 | 2020 |
| The fight against obesity escalates: new drugs on the horizon and metabolic implications D Tsilingiris, S Liatis, M Dalamaga, A Kokkinos Current obesity reports 9, 136-149, 2020 | 22 | 2020 |
| Sodiumglucose cotransporter2 inhibitors in obesity and associated cardiometabolic disorders: where do we stand NG Vallianou, D Tsilingiris, D Kounatidis, IG Lempesis, I Karampela, ... Pol Arch Intern Med 132 (10), 16342, 2022 | 19 | 2022 |
